Vignola Mark J. has filed 12 insider transactions across 1 company since November 2022.
Most recent transaction: a sale of 8129 shares of Terns Pharmaceuticals, Inc. ($TERN) on January 02, 2025.
Activity breakdown: 4 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2025 | Terns Pharmaceuticals, Inc. | $TERN | Vignola Mark J. | Chief Financial Officer | S | Common Stock | 8129 | $5.72 | 83,811.0000 | 79,507,474 | 8.84% | 0.01% |
| Jan. 6, 2025 | Terns Pharmaceuticals, Inc. | $TERN | Vignola Mark J. | Chief Financial Officer | S | Common Stock | 9059 | $5.80 | 74,752.0000 | 79,507,474 | 10.81% | 0.01% |
| Sept. 10, 2024 | Terns Pharmaceuticals, Inc. | $TERN | Vignola Mark J. | Chief Financial Officer | M | Common Stock | 10000 | $5.36 | 101,940.0000 | 71,259,239 | 10.88% | 0.01% |
| Sept. 10, 2024 | Terns Pharmaceuticals, Inc. | $TERN | Vignola Mark J. | Chief Financial Officer | S | Common Stock | 10000 | $11.00 | 91,940.0000 | 71,259,239 | 9.81% | 0.01% |
| Sept. 10, 2024 | Terns Pharmaceuticals, Inc. | $TERN | Vignola Mark J. | Chief Financial Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 55,000.0000 | 71,259,239 | 15.38% | 0.01% |
| May 31, 2024 | Terns Pharmaceuticals, Inc. | $TERN | Vignola Mark J. | Chief Financial Officer | P | Common Stock | 4791 | $4.44 | 91,940.0000 | 71,259,239 | 5.50% | 0.01% |
| Jan. 23, 2024 | Terns Pharmaceuticals, Inc. | $TERN | Vignola Mark J. | Chief Financial Officer | A | Common Stock | 68750 | $0.00 | 87,149.0000 | 71,259,239 | 373.66% | 0.10% |
| Jan. 23, 2024 | Terns Pharmaceuticals, Inc. | $TERN | Vignola Mark J. | Chief Financial Officer | A | Stock Option (Right to Buy) | 137500 | $0.00 | 137,500.0000 | 71,259,239 | 9999.99% | 0.19% |
| Nov. 30, 2023 | Terns Pharmaceuticals, Inc. | $TERN | Vignola Mark J. | Chief Financial Officer | P | Common Stock | 743 | $3.78 | 18,399.0000 | 0 | 4.21% | 0.00% |
| May 31, 2023 | Terns Pharmaceuticals, Inc. | $TERN | Vignola Mark J. | Chief Financial Officer | P | Common Stock | 9997 | $1.41 | 17,656.0000 | 0 | 130.53% | 0.00% |
| Nov. 30, 2022 | Terns Pharmaceuticals, Inc. | $TERN | Vignola Mark J. | Chief Financial Officer | P | Common Stock | 3 | $1.41 | 7,659.0000 | 0 | 0.04% | 0.00% |
| Feb. 1, 2023 | Terns Pharmaceuticals, Inc. | $TERN | Vignola Mark J. | Chief Financial Officer | A | Stock Option (Right to Buy) | 360000 | $0.00 | 360,000.0000 | 0 | 9999.99% | 0.00% |